Treatment of chronic lymphocytic B-leukemia (B-CLL) with human IL-2 [interleukin-2] and CD40 ligand and plasmid gene modified autologous tumor cells (CLIPA)
Phase of Trial: Phase I
Latest Information Update: 27 Apr 2010
At a glance
- Drugs Chronic lymphocytic leukaemia vaccine (Primary)
- Indications Leukaemia
- Focus Adverse reactions
- Acronyms CLIPA
- 31 Aug 2018 Biomarkers information updated
- 27 Apr 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 27 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.